RAP 0.00% 20.5¢ resapp health limited

Receives TGA approval for ResAppDx-EU version 2

  1. 471 Posts.
    lightbulb Created with Sketch. 34

    ResApp (ASX:RAP) receives TGA approval for ResAppDx-EU version 2



    • ResApp (RAP) has received Australian Therapeutic Good Administration (TGA) approval for version 2 of its smartphone app
    • This app uses machine learning algorithms that analyse a patient's cough sounds to diagnose diseases and provide timely and accurate information
    • Adults are now able to use the device to test for respiratory problems in addition to children and infants

    Click to view full article

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.